An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies.

Journal Information

Full Title: Clin J Pain

Abbreviation: Clin J Pain

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"GlaxoSmithKline Biologicals SA (Brentford, United Kingdom) funded this study (GSK study identifiers: 110390, 113077) and was involved in all stages of study conduct, including the analysis of the data. GlaxoSmithKline Biologicals SA also took charge of all costs associated with the development and publication of this article. C.B., D.C., E.S.C., and N.L. are employed by/hold shares in GSK. A.L.C. reports a grant from GSK and received honoraria paid to his institution Merck Serono (Merck, Darmstadt, Germany), and BioCSL/Sequirus (Melbourne, Australia) outside the submitted work. S.M. reports personal fees from GSK during the conduct of the study and outside the submitted work. N.L. reports patents planned, issued, or pending outside the submitted work. The remaining authors declare no conflict of interest."

Evidence found in paper:

"GlaxoSmithKline Biologicals SA (Brentford, United Kingdom) funded this study (GSK study identifiers: 110390, 113077) and was involved in all stages of study conduct, including the analysis of the data. GlaxoSmithKline Biologicals SA also took charge of all costs associated with the development and publication of this article. C.B., D.C., E.S.C., and N.L. are employed by/hold shares in GSK. A.L.C. reports a grant from GSK and received honoraria paid to his institution Merck Serono (Merck, Darmstadt, Germany), and BioCSL/Sequirus (Melbourne, Australia) outside the submitted work. S.M. reports personal fees from GSK during the conduct of the study and outside the submitted work. N.L. reports patents planned, issued, or pending outside the submitted work. The remaining authors declare no conflict of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025